Christopher P. Lowe Cortexyme, Inc. (CRTX) insider trading activity

Christopher P. Lowe is Interim CEO, COO & CFO of Cortexyme, Inc.. Currently has a direct ownership of 265,000 shares of CRTX, which is worth approximately $341,850. The most recent transaction as insider was on Mar 03, 2022, when has been sold 175,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K

0% 3M change

0% 12M change

Total Value Held $341,850

CHRISTOPHER P. LOWE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2022	BUY Grant, award, or other acquisition	-	175,000 Added 39.77%	265,000 Common Stock
Nov 16 2021	BUY Exercise of conversion of derivative security	$66,900 $2.23 p/Share	30,000 Added 25.0%	90,000 Common Stock
Oct 05 2021	SELL Open market or private sale	$488,856 $98.5 p/Share	4,963 Reduced 7.64%	60,000 Common Stock
Oct 05 2021	BUY Exercise of conversion of derivative security	$272,221 $54.85 p/Share	4,963 Added 7.1%	64,963 Common Stock
Aug 17 2021	BUY Exercise of conversion of derivative security	$66,900 $2.23 p/Share	30,000 Added 33.33%	60,000 Common Stock
Aug 16 2021	SELL Open market or private sale	$2,119,700 $96.35 p/Share	22,000 Reduced 42.31%	30,000 Common Stock
Aug 16 2021	BUY Exercise of conversion of derivative security	$49,060 $2.23 p/Share	22,000 Added 29.73%	52,000 Common Stock
Jun 30 2021	BUY Exercise of conversion of derivative security	$66,900 $2.23 p/Share	30,000 Added 50.0%	30,000 Common Stock
Jun 28 2021	SELL Open market or private sale	$1,094,000 $54.7 p/Share	20,000 Reduced 100.0%	0 Common Stock
Jun 28 2021	BUY Exercise of conversion of derivative security	$44,600 $2.23 p/Share	20,000 Added 50.0%	20,000 Common Stock

Also insider at

VINC

Vincerx Pharma, Inc. Healthcare

Director

CPL